NCT05879289已完成不适用
Avaliação de eficácia do Efeito Antienvelhecimento de um Suplemento Alimentar na Melhora Das condições da Pele - Estudo Clínico, Subjetivo e Instrumental
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Acceptability in real conditions of use by questionnaire
研究概览
简要总结
A unicentric, blind, non-comparative clinical study to evaluate facial and body anti-aging efficacy of a supplement in female participants through clinical, subjective and instrumental evaluations.
详细描述
A unicentric, blind, non-comparative clinical study to evaluate facial and body anti-aging efficacy of a supplemente in female participants through clinical, subjective and instrumental evaluations.
It will be necessary 33 female participants aged between 35 and 60 years old with signs of aging on the face and neck, complaining of body flaccidity and gynoid lipodystrophy.
The participant will remain in the study for 90 days using the product. Visits will be scheduled in D0, D45 and D90.
Instrumental evaluations: Evaluated on each visit:
- Skin elasticity and firmness using Cutometer - D0, D45 and D90;
- Skin hydration using Corneometer- D0,D45 and D90;
- Detection and accuracy of fine lines and wrinkles using Visia -D0,D45 and D90
- Dermal thickness and density in the thigh region using Ultrasound Voluson E8 before using the product (D0) and after 90 (D90) days of continuous use;
- Participants will respond to a subjective assessment using a questionnaire to capture possible feelings of discomfort during the study and subjective efficacy.
- A dermatologist will be available to monitor the participants throughout the study and respond an assessment of clinical efficiency
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 35 Years 至 65 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Signs of aging in the face and neck region (fine lines, furrows and expression lines);
- •Participants with complaints of body sagging;
- •Participants with BMI < 30 (body mass index less than 30);
- •Participants with Gynoid Lipodystrophy Grade 1 and/or 2;
- •Agreement to follow the trial procedures and attend the clinic on the days and times determined.
- •Ability to understand and consent to their participation in this clinical study, manifested by signing the Term of Free and Informed Consent (TCLE)
排除标准
- •Participants who have been diagnosed with COVID-19 by RT-PCR examination or by the presence of IgM antibodies in the serology exam, in the last 4 weeks or who are presenting any of the following symptoms: dry or productive cough, sneezing, runny nose, body ache, headache, anosmia (loss of smell), ageusia (loss of taste) and/or any other symptoms that may be related to covid-19 at the discretion of the investigator;
- •Pregnancy or risk of pregnancy/lactation;
- •Use of the following topical or systemic medications: immunosuppressants, antihistamines, anti-inflammatories non-hormonal drugs, and corticoids up to 30 days before selection or considering immunosuppressants, the interval should be 3 months before selection;
- •Atopic or allergic history to Food Supplements;
- •Pathologies and/or active skin lesions (local and/or disseminated) in the assessment area;
- •Skin marks in the experimental area that interfere with the evaluation of possible skin reactions (malformations vascular lesions, scars, increased hairiness, large nevus, sunburn);
- •Immunosuppression by drugs or active diseases;
- •Decompensated endocrinopathies;
- •Participants with known congenital or acquired immunodeficiency;
- •Relevant medical history or current evidence of alcohol or other drug abuse;
- •Known history or suspected intolerance to products of the same category;
- •Intense sun exposure up to 15 days before the evaluation;
- •Aesthetic or dermatological treatment in the evaluation areas up to 04 weeks before selection;
- •Professionals directly involved in carrying out this study;
- •Other conditions considered by the evaluating physician as reasonable for disqualification from participation in the study. If so, it should be described under observation in the clinical record
结局指标
主要结局
Acceptability in real conditions of use by questionnaire
时间窗: 90 days
Evaluate the effectiveness of the investigational product (nutritional supplement) in improving signs of facial and body aging, through clinical, instrumental and subjective evaluations. Confirm in real conditions of use, the absence of risk and irritation and capture feelings of discomfort in the population studied (0 meaning no risk)
次要结局
- Evaluation of skin firmness and elasticity using instrumental evaluation - Cutometer(Day 0, Day 45 e Day 90)
- Increase of skin hydration using instrumental evaluation - Corneometer(Day 0, Day 45 e Day 90)
- Increase in dermal thickness and density in the thigh region(Day 0 e Day 90)
- Acceptability in real conditions of use through dermatological questionnaire(Day 0, Day 45 e Day 90)
- Detection and accuracy of fine lines and wrinkles- Visia(Day 0, Day 45 e Day 90)
- Subjective efficacy from the participants(Day 45 e Day 90)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
Unknown
The study to investigate the anti-aging efficacy of intravenous infusion of nicotinamide mononucleotidehealthy subjectsJPRN-UMIN000049674Sense Skin Clinic50
已完成
不适用
Evaluation of the Anti-aging Efficacy of One Face Care Cosmetic ProductSkin AgingNCT06619457Amazentis SA36
进行中（未招募）
不适用
Antiageing efficacy of a food supplementMild-to-moderate skin agingSkin and Connective Tissue DiseasesISRCTN15779299ROELMI HPC80
已完成
不适用
TO CHECK THE EFFECT OF SKIN ANTI AGEING NUTRICOSMECTIC PRODUCT IN WOMECTRI/2011/10/002040Meiji India Private Ltd67
已完成
不适用
The Study of Anti-aging and Brightening Effects of Topical Vitamin C, Vitamin E, and Raspberry Leaf Cell Culture ExtractHave aging skin signs (fine lines/wrinkle,brown spots)TCTR20190418004MAX BIOCARE PTY LTD50